A rapid assessment of take-home naloxone provision during COVID-19 in Europe-Reference-Cited by-同舟云学术

A rapid assessment of take-home naloxone provision during COVID-19 in Europe

Published:2022-09 Issue: Volume:107 Page:103787
ISSN:0955-3959
Container-title:International Journal of Drug Policy
language:en
Short-container-title:International Journal of Drug Policy

Author:

McDonald Rebecca^ORCID,Eide Desiree,Abel-Ollo Katri,Barnsdale Lee,Carter Ben,Clausen Thomas^ORCID,Day Ed,Fonseca Francina^ORCID,Holmén Elin^ORCID,Horsburgh Kirsten,Kelleher Mike,Kåberg Martin,Ladenhauf Martin,McAuley Andrew^ORCID,Metrebian Nicola,Neale Joanne,Parkin Stephen^ORCID,Ratcliffe Kevin,Rintoul Chris,Smith Josie^ORCID,Stifanoviciute Viktorija,Torrens Marta,Thiesen Henrik,Strang John

Publisher

Elsevier BV

Subject

Health Policy,Medicine (miscellaneous)

Reference45 articles.

1. Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: A national qualitative assessment in Canada;Ali;International Journal of Drug Policy,2021

2. Catalan Public Health Agency. (2021). Sistema d'informació sobre drogodependències de Catalunya. Informe anual 2020[In Catalan]. https://drogues.gencat.cat/web/.content/minisite/drogues/professionals/observatori/Informe-SISTEMA-INFORMACIO-DROGODEPENDENCIES_Informe-anual-2020_ok.pdf

3. Centers for Disease Control. (2020a). Health alert network 2020. https://emergency.cdc.gov/han/2020/han00438.asp.

4. Centers for Disease Control. (2020b). Provisional drug overdose death counts 2020. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm#drug_specificity.

5. Addressing co-occurring public health emergencies: The importance of naloxone distribution in the era of COVID-19;Collins;International Journal of Drug Policy,2020

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Take-home naloxone administered in emergency settings: feasibility of intervention implementation in a cluster randomized trial;BMC Emergency Medicine;2024-08-29

2. Closing doors, opening windows – Adaptations and opportunities for harm reduction services during the COVID-19 pandemic in Europe;Drugs: Education, Prevention and Policy;2024-06-05

3. Is a definitive trial of Take-Home Naloxone in emergency settings indicated? Results of a cluster randomised feasibility study;2024-03-15

4. Flexible delivery of opioid agonist treatment during COVID-19 in Norway: qualitative and quantitative findings from an online survey of provider experiences;BMC Health Services Research;2023-09-07

5. Disruptions to naloxone training among lay and occupational responders in Maryland during the emergence of COVID-19: Early impacts, recovery, and lessons learned;Drug and Alcohol Dependence Reports;2023-09